Effect of early enteral nutrition on chronic pain scores among critically ill adults
Published
March 21, 2025
Paper ID
PAP-000140
Status
Published
DOI
10.65712/tmj.test000398
Advance Services
Abstract
Background: The cost of chronic pain scores to health systems is substantial. Methods: We conducted a randomised controlled trial across 5 centres between 2014 and 2022. Results: The adjusted odds ratio was 0.64 (95% CI 0.44 to 0.63). The adjusted odds ratio was 0.68 (95% CI 0.47 to 0.62). Conclusion: These findings suggest that early enteral nutrition is associated with better chronic pain scores in critically ill adults.
Introduction
Guidelines make only a weak recommendation on early enteral nutrition. The cost of chronic pain scores to health systems is substantial.
The cost of chronic pain scores to health systems is substantial. chronic pain scores remains a leading cause of avoidable harm among critically ill adults. Guidelines make only a weak recommendation on early enteral nutrition.
The cost of chronic pain scores to health systems is substantial. Earlier studies of early enteral nutrition were small or single-centre.
Discussion
Future work should test early enteral nutrition in a pragmatic multicentre trial. Residual confounding cannot be excluded. Implementation will depend on staffing, cost and local protocols.
Future work should test early enteral nutrition in a pragmatic multicentre trial. These findings suggest that early enteral nutrition is associated with better chronic pain scores in critically ill adults.
Residual confounding cannot be excluded. Future work should test early enteral nutrition in a pragmatic multicentre trial.
Residual confounding cannot be excluded. Implementation will depend on staffing, cost and local protocols. Strengths include the sample size and blinded outcome assessment.
Conclusions
Early enteral nutrition merits wider use for critically ill adults to improve chronic pain scores.
References
1. Kaur P, Farouk W, et al. A sepsis alert system and 30-day readmission. N Engl J Med. 2021;235(5):481-1066.
2. Rahman P, Haddad F, et al. Machine-learning triage and ventilator-free days. Ann Intern Med. 2011;51(2):183-1498.
3. Dubois I, Lindqvist N, et al. Pharmacist-led medication review and falls. Ann Intern Med. 2020;288(11):350-1089.
4. Novak N, Ahmed N, et al. Delayed cord clamping and emergency department revisits. JAMA. 2023;398(10):78-1330.
5. Patel C, Moreau M, et al. Tranexamic acid and length of stay. Crit Care Med. 2015;259(6):514-1747.
Appendices
Supplementary tables are available on request.
Materials and Methods
Missing data were handled with multiple imputation. The primary outcome was chronic pain scores, assessed blind to allocation. Analyses were adjusted for age, sex and baseline severity. Eligible participants were critically ill adults.
The primary outcome was chronic pain scores, assessed blind to allocation. Missing data were handled with multiple imputation. Eligible participants were critically ill adults.
Results
Effects were consistent across prespecified subgroups. Serious adverse events were rare and similar between groups. The adjusted odds ratio was 0.69 (95% CI 0.48 to 0.64).
| Group | n | Events | Rate % |
|---|---|---|---|
| Female | 275 | 94 | 5.0 |
| Age ≥ 65 | 365 | 33 | 34.7 |
| Intervention | 396 | 61 | 32.4 |
| Centre A | 183 | 119 | 10.8 |
| Control | 150 | 38 | 38.6 |
| Age ≥ 65 | 589 | 12 | 2.4 |
Values are n (%) unless stated otherwise.

Shown for critically ill adults; error bars are 95% confidence intervals.

Shown for critically ill adults; error bars are 95% confidence intervals.
Effects were consistent across prespecified subgroups. 3550 participants were included (median age 37 years).
Serious adverse events were rare and similar between groups. The adjusted odds ratio was 0.89 (95% CI 0.23 to 0.61). The adjusted odds ratio was 0.90 (95% CI 0.44 to 0.80). The adjusted odds ratio was 0.80 (95% CI 0.27 to 0.78).